ZNTL (Zentalis Pharmaceuticals Inc) stock is currently covered by 6 analysts. The average analyst rating isĀ 4.8 out of 5.

ZNTL analysts have given it a high price target of $75, mean price target of $66.4, and a low price target of $63.

ZNTL currently has an estimated 12-Month price forecast of $66.4 based on the average analyst price target.

[wpdatatable id=10 var1=ZNTL]

Leave a Reply

Your email address will not be published. Required fields are marked *